We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Level up your trading with our powerful tools and real-time insights all in one place.
The current DXCM market cap is 32.03B. The company's latest EPS is USD 1.4745 and P/E is 55.58.
| Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 1.03B | 921M | 1B | 994.2M | 1.11B |
| Operating Income | 217.6M | 101.1M | 158M | 152M | 194M |
| Net Income | 256.3M | 146.4M | 143.5M | 134.6M | 151.7M |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 1.93B | 2.45B | 2.91B | 3.62B | 4.03B |
| Operating Income | 299.5M | 277.4M | 391.2M | 598.4M | 605.1M |
| Net Income | 493.6M | 154.7M | 341.2M | 541.5M | 576.2M |
| Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 6.26B | 6.48B | 6.8B | 6.35B | 6.48B |
| Total Liabilities | 4.2B | 4.24B | 4.36B | 4.37B | 4.38B |
| Total Equity | 2.07B | 2.25B | 2.43B | 1.98B | 2.1B |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 4.29B | 4.86B | 5.39B | 6.26B | 6.48B |
| Total Liabilities | 2.46B | 2.61B | 3.26B | 4.2B | 4.38B |
| Total Equity | 1.83B | 2.25B | 2.13B | 2.07B | 2.1B |
| Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | 748.5M | 209.2M | 488.6M | 688.1M | 989.5M |
| Investing | -507.2M | 74.8M | -114.1M | 96.2M | -207.5M |
| Financing | -318.6M | 4.7M | 3.3M | -733.2M | -734.8M |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | 475.6M | 442.5M | 669.5M | 748.5M | 989.5M |
| Investing | -1.02B | -216.1M | -521.5M | -507.2M | -207.5M |
| Financing | 912.1M | 10.4M | -552.5M | -318.6M | -734.8M |
| Market Cap | 32.03B |
| Price to Earnings Ratio | 55.58 |
| Price to Sales Ratio | 7.94 |
| Price to Cash Ratio | 52.84 |
| Price to Book Ratio | 15.23 |
| Dividend Yield | - |
| Shares Outstanding | 390.77M |
| Average Volume (1 week) | 4.02M |
| Average Volume (1 Month) | 3.95M |
| 52 Week Change | -35.00% |
| 52 Week High | 142.00 |
| 52 Week Low | 62.34 |
| Spread (Intraday) | 0.7 (0.85%) |
| Company Name | DexCom Inc |
| Address |
251 little falls drive wilmington, delaware 19808 |
| Website | https://www.dexcom.com |
| Industry | surgical,med instr,apparatus (3841) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
